文献速递妇科

麻醉阻滞用于子宫内膜消融术疼痛的效果:一项随机对照试验

Utility of anesthetic block for endometrial ablation pain: a randomized controlled trial.
PubMed 文献 · Am J Obstet Gynecol · 2017-11-15

该单中心单盲随机对照试验纳入84例30至55岁、因良性疾病行门诊子宫内膜消融术的绝经前女性,比较消融结束时宫颈旁注射20 mL 0.25%布比卡因与20 mL生理盐水对术后疼痛及麻醉药使用的影响。治疗组术后1小时VAS疼痛评分较对照组低1.3分(P=0.02),术后麻醉药用量较对照组少3.6吗啡当量(P=0.05),但4小时和8小时差异无统计学显著。作者认为局部麻醉联合全身麻醉可减轻术后1小时疼痛并减少麻醉药使用,需进一步研究以确定结果可否推广及最佳给药时机。

要点

  • 消融结束时宫颈旁注射0.25%布比卡因20 mL,术后1小时VAS疼痛评分较生理盐水组低1.3分(P=0.02)。
  • 治疗组术后麻醉药用量较对照组少3.6吗啡当量(P=0.05)。
  • 术后4小时(P=0.31)和8小时(P=0.62)疼痛评分差异无统计学显著。

核心结论

  • 该随机对照试验发现,并发症风险低的局部麻醉联合全身麻醉可减轻子宫内膜消融术后1小时疼痛并显著减少术后麻醉药使用。
  • 需进一步研究以确定研究结果是否可推广,以及术后是否为给予宫颈旁阻滞以减轻子宫内膜消融疼痛的最佳时机。

研究设计与样本

  • 单中心单盲随机对照试验,在学术附属社区医院开展。
  • 共筛查108例计划行子宫内膜消融术的女性(拒绝21例,不符合条件3例),随机84例30至55岁、因良性疾病行门诊子宫内膜消融术的英语绝经前女性。
  • 按2例区组随机,每臂42例;治疗组于消融结束时宫颈旁注射20 mL 0.25%布比卡因,对照组注射20 mL生理盐水。
  • 样本量估算:以两组平均VAS评分标准差为75%、双侧检验、I类错误5%、把握度80%,检验1小时平均VAS疼痛评分差异40%,每组需36例,假设15%脱落率后每组入组42例。
  • 意向性治疗分析纳入1例错误随机(提供者 conscious 决定不按方案给予镇痛,随后该提供者被排除进一步参与研究)及3例因手术困难未行消融者;3例失访第二天随访。

主要发现

  • 治疗组(n=41)术后1小时VAS疼痛评分较对照组(n=41)低1.3分(P=0.02)。
  • 疼痛评分差异在4小时时减弱(P=0.31),8小时时微不足道(P=0.62)。
  • 治疗组术后镇痛药用量较对照组少3.6吗啡当量(P=0.05)。
  • 回归分析控制混杂后,治疗组术后1小时疼痛评分差异降至0.8(置信区间[CI],-0.6至0.1),术后平均吗啡当量略增至3.7(CI,-6.8至-0.7)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需进一步研究以确定研究结果是否可推广。
  • 需进一步研究以确定术后是否为给予宫颈旁阻滞以减轻子宫内膜消融疼痛的最佳时机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Second-generation endometrial ablation has been demonstrated safe for abnormal uterine bleeding treatment, in premenopausal women who have completed childbearing, in short-stay surgical centers and in physicians' offices. However, no standard regarding anesthesia exists, and practice varies depending on physician or patient preference and hospital policy and setting. OBJECTIVE: The aim of this study was to evaluate whether local anesthetic, in combination with general anesthesia, affects postoperative pain and associated narcotic use following endometrial ablation. MATERIALS AND METHODS: This was a single-center single-blind randomized controlled trial conducted in an academic-affiliated community hospital. A total of 84 English-speaking premenopausal women, aged 30 to 55 years, who were undergoing outpatient endometrial ablation for benign disease were randomized to receive standardized paracervical injection of 20 mL 0.25% bupivacaine (treatment group) or 20 mL normal saline solution (control group) upon completion of ablation. The study was designed to test a 40% 1-hour mean visual analog scale (VAS) pain score difference with an average standard deviation of 75% of both groups' mean VAS scores, using a 2-tailed test, a type I error of 5%, and statistical power of 80%. A sample of 36 patients per study group was required. Assuming a 15% attrition rate, the study enrolled 42 patients per study arm randomized in blocks of 2 (84 total). Two-tailed cross-tabulations with Fisher exact significance values where appropriate and Student t tests were used to compare patient characteristics. Backward stepwise regressions were conducted to control for confounding. RESULTS: Between April 2016 and February 2017, a total of 108 women scheduled for endometrial ablation were screened (refusals, n = 21; ineligible, n = 3) to determine whether there were meaningful differences in postoperative VAS pain scores and postoperative narcotic use. Of the 84 randomized women, 2 age-ineligible women were excluded. Intent-to-treat analyses included 1 incorrect randomization (in which the provider consciously decided to provide analgesia regardless of the protocol, after which the provider was excluded from further study participation) and 3 women having no ablation because of operative difficulties. Three were lost to second-day follow-up. Treatment group patients (n = 41) experienced 1.3 points lower 1-hour postoperative VAS pain scores than the control group (n = 41, P = .02). The difference diminished by 4 hours (P = .31) and was negligible by 8 hours (P = .62). Treatment group patients used 3.6 less morphine equivalents of postoperative pain medication (P = .05). Regression analyses controlled for confounding reduced the 1-hour postoperative treatment group pain score difference to 0.8 (confidence interval [CI], -0.6 to 0.1) but slightly increased the average postoperative morphine equivalents to 3.7 (CI, -6.8 to -0.7). CONCLUSION: This randomized controlled trial found that local anesthetic with low risk for complications, used in conjunction with general anesthesia, decreased postoperative pain at 1 hour and significantly reduced postoperative narcotic use following endometrial ablation. Further research is needed to determine whether the study results are generalizable and whether post procedure is the best time to administer the paracervical block to decrease endometrial ablation pain.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Klebanoff JS, Patel NR, Sloan NL, et al. Utility of anesthetic block for endometrial ablation pain: a randomized controlled trial. Am J Obstet Gynecol. 2017. PMID: 29155035. doi:10.1016/j.ajog.2017.11.571

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。